Happiest Minds Technologies Management Guidance Tracker

Management reiterated 25% revenue growth guidance for FY24, inclusive of both organic and inorganic contributions. May update later in the year based on M&A progress.

Management revised the full-year organic revenue growth guidance to 12% from a previous composite (organic+inorganic) target of 35%, citing a large acquisition that did not close and a cautious demand environment.

Management reiterated the annual guidance of 12% YoY CC growth, implying a QoQ growth of ~4.5% in Q4.

Management estimates FY25 revenue growth of 35-40%, including contributions from acquisitions and organic growth.

Management reaffirmed the vision to achieve $1 billion in revenue by 2031, requiring a 22% CAGR from FY25.

Management revised revenue growth guidance from 35-40% to 30-35% due to delayed closure of acquisitions, but remains confident of strong absolute growth.

Management reiterated full-year revenue growth guidance of 30-35%, expecting Q4 to be stronger than Q3 due to large deal closures.

Management expects to close at least two large Arttha banking platform license deals in the next two quarters, with Q4 being the strongest.

Management aims to close FY25 with constant currency growth as close to 30% as possible, with Q4 expected to show strong sequential growth.

The flagship unified banking platform ARTA is expected to grow revenues by 20-25% in the current fiscal year.

22 replicable AI use cases in GBS represent a revenue potential of nearly $15 million over the next three to four years.

The 30 new clients added in H1 are expected to generate $50-60 million in revenue over the next three to four years.

Management reaffirmed the commitment to deliver 10%+ revenue growth in constant currency for the current financial year.

EBITDA margin guidance maintained at 20%-24%, with Q1 delivering 25.5%. Wage hikes effective July may temporarily impact margins.

The company retains its EBITDA margin guidance of 22%-24% for FY24.

Company has beaten this guidance for 15 consecutive quarters and expects to maintain within this range.

EBITDA margin expected to be in the range of 22-24% for FY25, considering investments and acquisition integration.

EBITDA margin guidance maintained at 20-22% for the full year, with Q1 coming in at 23.9%.

Annual pay increases effective July 1 will impact margins by 250-280 bps, and Q2 has fewer billing days, but management expects EBITDA to remain within the 20-22% band.

EBITDA margin is expected to remain in the 20-22% range for the full year, with Q3 impacted by fewer working days and leadership pay hikes.

Management expects to end FY25 with EBITDA margins within the guided range of 20-22%, with nine-month EBITDA margin at 22.1%.

EBITDA margin is guided to remain in the 20-22% range for FY26, despite wage hikes and continued investments.

The GenAI business unit, which broke even at operating margin level in Q1, is expected to achieve profitability levels comparable to the TDES segment by year-end or early next year.

Management reiterated its aspiration to sustain EBITDA margins in the 20%-22% range for FY 2026.

EBITDA margin is expected to remain in the 20-22% range for the current financial year.

Establishing a dedicated GenAI division with an initial team of 100+ experts to drive use cases and solutions across domains.

Approximately 15 GenAI proof-of-concept projects are expected to convert into significant orders and projects in the next fiscal year.

Long-term goal of reaching $1 billion in revenue by FY31, with organic and inorganic growth contributing.

The newly created Generative AI Business Services unit will not contribute meaningful revenue until the beginning of the next financial year.

The company reiterated its vision to achieve $1 billion in sales by FY 2031.

Management expects GenAI to be transformational from next year, with multiple POCs converting to orders.

The Generative AI business unit is expected to scale from 70 to 250 employees by the end of the fiscal year.

Management reiterated long-term target of $1 billion revenue by FY31, supported by acquisitions and organic growth.

Management aims for double-digit organic growth in FY26, driven by GenAI, new sales engine, and verticalization.

Management expects to deliver double-digit growth in constant currency for the full fiscal year, with H2 expected to be stronger than H1.

Management raised its commitment from three to four consecutive years of double-digit revenue growth in constant currency, through FY 2028.

Management expects to announce a significant increase in the growth guidance (above the 10% committed) when Q4 results are released.

The company plans to scale its AI and Gen AI team to 1,000 employees by the end of FY2027.

A new delivery center with 120-150+ seats in Hyderabad will become operational during Q3 FY25 to support capacity expansion.